Inflammation

, Volume 14, Issue 5, pp 585–597 | Cite as

Effects of dietary supplementation with eicosapentaenoic acid or gamma-linolenic acid on neutrophil phospholipid fatty acid composition and activation responses

  • Mark P. Fletcher
  • Vincent A. Ziboh
Original Articles

Abstract

Previous data that alimentation with fish oil rich in eicosapentaenoic acid (EPA; 20: 5n-3) or vegetable oil rich in gamma-linolenic acid (GLA; 18: 3n-6) can reduce symptoms of inflammatory skin disorders lead us to determine the effects of dietary supplements of oils rich in EPA or GLA on guinea pig (GP) neutrophil (PMN) membrane potential (δγ), secretion, and Superoxide (O 2 ) responses. Weanling GPs were initially fed diets supplemented with olive oil (<0.1% EPA; <0.1% GLA) for 2 weeks, followed by a crossover by two sets of animals to diets supplemented with fish oil (19% EPA) or borage oil (25% GLA). At 4-week intervals, 12% sterile casein-elicited peritoneal neutrophils (PMN) were assessed for membrane polyunsaturated fatty acid (PUFA) profiles and FMLP-, LTB 4 s- , and PMA-stimulated δγ changes, changes in flow cytometrically measured forward scatter (FWD-SC) (shape change), 90‡ scatter (90‡-SC) in cytochalasin B-pretreated-PMN (secretion response), and Superoxide responses. GP incorporated EPA and GLA (as the elongation product, dihomo-GLA or DGLA) into their PMN phospholipids by 4 weeks. The peritoneal PMN of all groups demonstrated broad resting FWD-SC and poor activation-related FWD-SC increases, suggesting in vivo activation. While secretion was comparable in the three groups in response to FMLP, there was a trend toward inhibition of LTB4-stimulated 90‡-SC loss in both fish and borage oil groups. This was significant only with borage oil (21.7±2.1 vs 15.3±1.2% loss of baseline 90‡-SC, olive vs borage;P=0.03). PMN from borage- and fish oil-fed GPs showed a progressively lower O 2 response to FMLP than the olive oil group (73.9±3.9 and 42.9±6.8% of olive oil response for borage and fish oils, respectively;P< 0.005 andP<0.01, respectively, at 12 weeks), while PMA-stimulated O 2 was inhibited only in the fish oil-fed group and only at 12 weeks (62.0±2.7% of control;P<0.025). We conclude that dietary supplementation with oils rich in PUFAs can modify PMN activation responses.

Keywords

Eicosapentaenoic Acid Cytochalasin Phospholipid Fatty Acid Composition Peritoneal Neutrophil Membrane Polyunsaturated Fatty Acid 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Coman, D. R. 1940. Chemotaxis of monocytes contrasted with that of polymorphonuclear leukocytes and lymphocytes.Arch. Pathol. 30:896.Google Scholar
  2. 2.
    Metchnikoff, E. 1907.Immunity in Infective Diseases, translated by F. A. Starling and E. H. Starling. Paul Trench Trubner, London.Google Scholar
  3. 3.
    Barrett, A. J. 1978. The possible role of neutrophil proteinases in damage to articular cartilage.Agents Actions 8:11–18.Google Scholar
  4. 4.
    Kunkel, S. L., R. S. Thrall, R. G. Kunkel, J. R. McCormick, P. A. Ward, andR. B. Zurier. 1979. Suppression of immune complex vasculitis in rats by prostaglandins.J. Clin. Invest. 64:1525–1529.Google Scholar
  5. 5.
    Jacob, H. S., P. R. Craddock, D. E. Hammerschmidt, andC. F. Moldon. 1980. Complement-induced granulocyte interaction: On unsuspected mechanism of disease.N. Engl. J. Med. 302:789–794.Google Scholar
  6. 6.
    Ziboh, V. A., C. Miller, K. Kragballe, K. Cohen, C. Ellis, andJ. J. Voorhees. 1986. Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids: Modulation of clinical course of psoriatic subjects.Arch. Dermatol. 122:1277–1282.Google Scholar
  7. 7.
    Romson, J. L., B. G. Hook, S. L. Kunkel, G. D. Abrams, M. A. Schork, andB. R. Lucchesi. 1983. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.Circulation 67:1016–1023.Google Scholar
  8. 8.
    Zurier, R. B. 1982. Prostaglandins, immune responses and murine lupus.Anh. Rheum. 25:804–809.Google Scholar
  9. 9.
    Robinson, D. R., J. D. Prickett, R. Polisson, A. D. Steinberg, andL. Levine. 1985. The protective effect of dietary fish oil on murine lupus.Prostaglandins 30:51–75.Google Scholar
  10. 10.
    Kremer, J. M., J. Bigauoette, A. V. Michalek, M. A. Timchalk, L. Lininger, R. I. Rynes, C. Huyck, J. Zieminski, andL. E. Bartholomew. 1985. Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis.Lancet 1:184–187.Google Scholar
  11. 11.
    Kromann, N., andA. Green. 1980. Epidemiological studies in the Upernavik District, Greenland.Acta Med. Scand. 208:401–406.Google Scholar
  12. 12.
    Wright, S., andJ. L. Burton. 1982. Oral evening primrose-seed oil improves atopic eczema.Lancet 2:1120–1123.Google Scholar
  13. 13.
    Miller, C. C., C. A. Mccreedy, A. D. Jones, andV. A. Ziboh. 1988. Oxidative metabolism of dihomogammalinolenic acid by guinea pig epidermis: Evidence of generation of anti-inflammatory products.Prostaglandins 35:917–938.Google Scholar
  14. 14.
    Fletcher, M. P. 1987. Prostaglandin E1 (PGE1) inhibits FMLP-mediated depolarization responses by decreasing the proportion of responsive cells without affecting chemotaxin induced forward light scatter changes.J. Immunol. 139:4167–4173.Google Scholar
  15. 15.
    Zurier, R. B. 1982. Use of prostaglandins and evening primrose oil (Efamol) in experimental models of inflammation.In Clinical Uses of Essential Fatty Acids. D. F. Horrobin, editor, Eden Press, Montreal, p. 113.Google Scholar
  16. 16.
    Miller, C. C., V. A. Ziboh, T. Wong, andM. P. Fletcher. 1990. Dietary supplementation with n-3 and n-6 enriched oils influences in vivo levels of epidermal lipoxygenase products.J. Nutr. 120:36–44.Google Scholar
  17. 17.
    Chapkin, R. S., V. A. Ziboh, andJ. L. McCullough. 1987. Dietary influences of evening primrose and fish oil on the skin of essential fatty acid-deficient guinea pigs.J. Nutr. 117:1360–1370.Google Scholar
  18. 18.
    Zimmerli, W., B. Seligmann, andJ. I. Gallin. 1986. Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression.J. Clin. Invest. 77:925–933.Google Scholar
  19. 19.
    Folch, J., M. Lees, andG. H. Sloane-Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues.J. Biol. Chem. 22:497–509.Google Scholar
  20. 20.
    Fletcher, M. P., andB. E. Seligmann. 1985. Monitoring human neutrophil granule secretion by flow cytometry: Secretion and membrane potential changes assessed by light scatter and a fluorescent probe of membrane potential.J. Leuk. Biol. 37:431–447.Google Scholar
  21. 21.
    Fletcher, M. P. 1986. Modulation of the heterogeneous f-met-leu-phe-induced membrane potential response of neutrophils by leukotriene B4: Evidence for cell recruitment.J. Immunol. 136:4213–4219.Google Scholar
  22. 22.
    Seligmann, B., T. M. Chused, andJ. I. Gallin. 1981. Human neutrophil heterogeneity identified using flow microfluorometry to monitor membrane potential.J. Clin. Invest. 68:1125–1131.Google Scholar
  23. 23.
    Fletcher, M. P., andJ. C. Gasson. 1988. Enhancement of neutrophil function, granulocytemacrophage colony stimulating factor (GM-CSF) involves recruitment of a less responsive subpopulation.Blood 71:652–658.Google Scholar

Copyright information

© Plenum Publishing Corporation 1990

Authors and Affiliations

  • Mark P. Fletcher
    • 1
  • Vincent A. Ziboh
    • 2
  1. 1.Division of Rheumatology/Allergy and Clinical Immunology, Department of Internal MedicineUniversity of CaliforniaDavis
  2. 2.Department of DermatologyUniversity of CaliforniaDavis

Personalised recommendations